Company Announcements

Issue of Ordinary Shares

Source: RNS
RNS Number : 6353I
Geiger Counter Ltd
19 April 2022
 

19 April 2022

GEIGER COUNTER LIMITED
(THE "COMPANY")

Issue of Ordinary Shares

The Company announces that, conditional only on Admission becoming effective, it has allotted, by way of a new issue in response to market demand 1,065,000 new ordinary shares of no par value (the "New Shares") for cash, at a price of 74 pence per share, a premium to the Company's net asset value. The New Shares will rank pari passu with the existing ordinary shares.

Applications will be made for the New Shares to be admitted to The International Stock Exchange's Listing and to trading on the London Stock Exchange's SETSqx platform ("Admission"). Admission is expected to become effective, and dealings in the New Shares are expected to commence, at 8.00 a.m. on 25 April 2022.

Following the issue of the New Shares, the Company's issued share capital will consist of 116,056,977 ordinary shares, none of which are held in treasury.

Enquiries

CQS (UK) LLP

Craig Cleland

T: +44 (0) 20 7201 5368

finnCap Limited

William Marle/Milesh Hindocha

T: +44 (0) 20 7220 0500

R&H Fund Services (Jersey) Limited

Jane De Barros-Sousa

T :+44 (0) 1534 825 259

Important Information

The information contained in this announcement does not constitute an offer of securities for sale in any jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBKCBNNBKDQQD